Eric J Hsu
6PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 08, 2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.Eric J Hsu, Timothy A Lin, Dor R Dabush
|Nov 02, 2021
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells.Longchao Liu, Jiahui Chen, Joonbeom Bae
|Oct 08, 2021
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance.Xuezhi Cao, Yong Liang, Zhenxiang Hu
|May 14, 2021
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.Eric J Hsu, Xuezhi Cao, Benjamin Moon
|Aug 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.Zhida Liu, Chuanhui Han, Chunbo Dong
Pageof 1
Frequent Collaborators
3 joint publications
Yang-Xin Fu
2 joint publications
Zhichen Sun
2 joint publications
Longchao Liu
2 joint publications
Casey Timmerman
2 joint publications
Huiyu Li
2 joint publications
Joonbeom Bae
1 joint publications
Chuanhui Han
1 joint publications
Chunbo Dong
1 joint publications
Zhenhua Ren
1 joint publications
Changzheng Lu
